Overview

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antidepressant effectiveness of Geodon for the treatment of patients diagnosed with Bipolar II disorder who are currently experiencing a major depressive episode.
Phase:
Phase 4
Details
Lead Sponsor:
The Medical Research Network
Collaborators:
Liebowitz, Michael R., M.D.
Pfizer
Treatments:
Ziprasidone